Stay updated on Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial page
- CheckyesterdayChange DetectedNew government funding lapse notice added at the top, informing users that information may not be up to date and directing them to opm.gov for status updates. Page revision shown updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.3%

- Check8 days agoChange DetectedAdded new metadata fields: Results First Posted; Last Update Submitted that Met QC Criteria; Last Update Posted, and removed certain fields: Results First Posted (Estimated) and No FEAR Act data. The glossary toggle was added and the site version updated to v3.4.0.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check44 days agoChange DetectedThe Locations section now lists multiple study sites across the United States (California, Connecticut, District of Columbia, Illinois, Massachusetts, New Jersey, New York, Oregon, Pennsylvania, Wisconsin) and Navarre, Spain.SummaryDifference0.9%

- Check66 days agoChange DetectedNew labels in Study Record Dates show 'Results First Posted (Estimated)' and 'Last Update Posted (Estimated)' and the page shows 'Revision: v3.3.2'; these are metadata/display changes that do not affect the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded a Results Posted section detailing Stage 1 efficacy outcomes (ORR, PFS, OS, DOR, DC) with RECIST v1.1 definitions and the 'Results First Posted' metadata. Removed several older endpoint descriptions and timing details from the results reporting.SummaryDifference2%

Stay in the know with updates to Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combinations in Metastatic Pancreatic Cancer Clinical Trial page.